Skip to main content
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Sexual health
  4. Pregnancy related
  5. Back
  6. Pregnancy - STIs and group B (GBS) streptococcal colonisation
  7. Syphilis
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Syphilis

Warning
  • All pregnant women should have serological testing for syphilis at their first antenatal assessment. Tests should be repeated later in pregnancy if a woman has been at risk of infection after a negative initial screen.
  • In the UK in 2011 approximately 0.15% of women had a positive antenatal test. Of these:
    • 46% had been adequately treated for syphilis before conception
    • 23% had false positive tests
    • 21% were diagnosed and required treatment for the first time during the current pregnancy
  • Although fetal infection usually occurs late in pregnancy it has been demonstrated as early as 8-9 weeks of gestation. This may result in polyhydramnios, miscarriage, preterm labour, still birth and hydrops.
  • In untreated early syphilis 70-100% of infants will be infected, with still births occurring in up to one third of cases.
  • Ten percent of infants born to mothers with late infection will be affected.
  • Babies born with congenital syphilis can have early manifestations of the disease (within the first 2 years of life) or late manifestations (after 2 years of life) including the stigmata of congenital syphilis.
  • Syphilis in pregnancy should be managed as clinically urgent and requires a multi disciplinary approach between sexual health, obstetrics and fetal medicine/paediatrics.
  • It has to be clearly established who is the Sexual Health clinician responsible for coordinating the treatment of the pregnant women and who has responsibility for
    liaising with the neonatologist.
  • Where syphilis was cured prior to current pregnancy the RPR/VDRL titres should be checked at the first antenatal booking appointment and repeated at 28 weeks gestation. If the RPR/VDRL excludes reinfection and there is no ongoing risk of infection, the women requires no further treatment and there is no need for the neonate to undergo tests for syphilis.
  • Retreatment of women with a history of syphilis treated before conception should be considered when
    • There is uncertainty about the adequacy of treatment based on history
    • Serological cure (i.e. a 4 fold drop in RPR/VDRL titre) did not occur.
  • A pregnant woman’s treatment should be appropriate for the stage of syphilis diagnosed (see BASHH Syphilis Guideline) with comprehensive follow up to minimise the likelihood of her developing long term complications of untreated/inadequately treated syphilis.
    • If treating early syphilis in the third trimester a second dose of benzathine penicillin should be given one week later due to lower serum levels of the drug and risk of treatment failure
  • Treatment with macrolides is no longer a treatment option as it may result in treatment failure and transmission to neonate. For pregnant women who report intolerance or allergy to penicillin or other beta-lactam antibiotics please refer to the detailed BASHH Syphilis Guideline and consult with senior colleagues.
  • The Jarisch-Herxheimer reaction may occur just as in non pregnant women. This may cause uterine contractions and fetal heart rate decelerations, as a result of maternal fever. There is a theoretical increased risk of spontaneous and iatrogenic preterm delivery and fetal demise associated with the reaction, though these complications are also associated with syphilis infection. Management should be supportive and include antipyretics. Steroids are not effective in reducing these effects.
  • Additional fetal scanning and monitoring may be indicated. This should be discussed by the multi-disciplinary team.
  • All children born to mothers with positive serology require referral to fetal medicine/paediatricians for clinical evaluation and syphilis serology tests, with the following exceptions
    • maternal biological false positive serology
    • maternal syphilis cured prior to this pregnancy
  • Treatment for congenital syphilis is needed in infants
    • born to mothers treated less than 4 weeks prior to delivery
    • suspected of having congenital syphilis
    • born to mothers treated with non penicillin regimens
    • born to mothers without documented evidence of adequate treatment
  • Partner notification is essential to reduce the possibility of re-infection of a pregnant woman (and unborn child). Untested older siblings may need testing for syphilis.

 

Editorial Information

Last reviewed: 31/01/2024

Next review date: 31/01/2026

Author(s): West of Scotland Managed Clinical Network for Sexual Health Clinical Guidelines Group .

Version: 6.1

Approved By: West of Scotland Managed Clinical Network in Sexual Health